UC San Diego Researchers Develop Gene Therapy to Combat Neurodegenerative Diseases
Experimental Gene Therapy Shields Brain from Toxic Protein Damage
Image: Uc San Diego Today
Researchers at the University of California, San Diego, have developed an experimental gene therapy that protects brain cells from damage caused by the toxic protein TDP-43, which is linked to frontotemporal dementia and Alzheimer's disease. The therapy enhances neuronal resilience and has shown promising results in mice, potentially paving the way for new treatments for neurodegenerative disorders.
- 01The gene therapy, named SynCav1, utilizes a modified virus to deliver a protective gene to brain cells.
- 02In mice, SynCav1 improved memory and learning while reducing levels of pathological TDP-43 in critical brain regions.
- 03The therapy demonstrated protective effects on mitochondria and neuronal communication structures.
- 04The study highlights the importance of enhancing neuronal resilience rather than solely targeting toxic proteins.
- 05The research was published in 'Alzheimer's & Dementia: The Journal of the Alzheimer's Association' and funded by various health organizations.
Advertisement
In-Article Ad
A study led by researchers at the University of California, San Diego School of Medicine has introduced an experimental gene therapy aimed at combating the detrimental effects of TDP-43, a protein implicated in several neurodegenerative diseases, including frontotemporal dementia (FTD) and Alzheimer's disease (AD). The therapy, known as SynCav1, utilizes a modified harmless virus to deliver a beneficial gene to brain cells, significantly enhancing their resilience against damage. In tests conducted on mice, the therapy successfully crossed the blood-brain barrier, leading to increased expression of caveolin-1, a neuroprotective protein. Results showed that SynCav1 preserved learning and memory functions while lowering pathological TDP-43 levels in the cortex and hippocampus. Additionally, the therapy provided protection to mitochondria and neuronal communication structures, suggesting a comprehensive approach to neuroprotection. The findings indicate that strengthening neurons may serve as a promising strategy for treating neurodegenerative diseases, opening avenues for further research and potential clinical applications.
Advertisement
In-Article Ad
The gene therapy could significantly alter treatment approaches for neurodegenerative diseases, affecting patients suffering from conditions like Alzheimer's and frontotemporal dementia.
Advertisement
In-Article Ad
Reader Poll
How do you feel about the potential of gene therapy for treating neurodegenerative diseases?
Connecting to poll...
More about University of California San Diego
Read the original article
Visit the source for the complete story.